Publications by authors named "Langling Rao"

Claim this Profile
C
Cost-effectiveness of HLX01 (Hanlikang) vs. rituximab combined with CHOP in treatment-naive diffuse large B-Cell lymphoma: a partitioned survival model analysis.
Chang Wang, Yuanqing Huang, Langling Rao, Chunling Yu, Yingxin Zhang

Front Pharmacolยท October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis